[EFFECT OF PHARMACOLOGICAL AGENTS ON THE DEVELOPMENT OF MYOCARDIAL LESIONS CAUSED BY BIOGENIC SUBSTANCES].
D000809:Angiotensins; D002415:Cats; D004562:Electrocardiography; D008996:Monoamine Oxidase Inhibitors; D009203:Myocardial Infarction; D010600:Pharmacology; D012106:Research; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013562:Sympathectomy; D014628:Vagotomy; D014665:Vasodilator Agents
D000809:Angiotensins; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014665:Vasodilator Agents
ANGIOTENSIN; CATS; ELECTROCARDIOGRAPHY; EXPERIMENTAL LAB STUDY; MONOAMINE OXIDASE INHIBITORS; MYOCARDIAL INFARCT; PHARMACOLOGY; SEROTONIN; SEROTONIN INHIBITORS; SYMPATHECTOMY; VAGOTOMY; VASODILATOR AGENTS
VLIIANIE FARMAKOLOGICHESKIKH SREDSTV NA RAZVITIE POVREZHDENI I MIOKARDA, VYZVANNYKH BIOGENNYMI VESHCHESTVAMI.